The Section of Rheumatology is a dynamic and growing enterprise of approximately forty faculty, staff and fellows who are committed to providing outstanding state-of-the-art patient care, understanding the pathogenesis of autoimmune diseases and training the next generation of physicians and scientists. The Section was recently named one of the top twenty programs in the country by US News and World Report (July, 2005).

Through our disease-focused clinics we offer an inter-disciplinarily approach to patient care that provides access to the most current therapies and to the resources of the University. In parallel with our clinical activities, we have well-developed basic science research programs where our primary focus is on understanding the development and regulation of lymphocytes which is fundamental to the pathogenesis of most autoimmune diseases.

These are exciting times in Rheumatology. Remarkable advances in our knowledge of basic immunology are beginning to translate into new and better treatments for those suffering from autoimmune and metabolic diseases. The Section is well poised to both take advantage and contribute to these revolutions in the understanding and treatment of rheumatic diseases.